Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Other Routine +

Novacium Signs Letter of Intent with GH Technologies for the Supply of GEN4 Li-Ion Cells and Batteries in Asia

HPQ Silicon Advances Asian Battery Footprint with Novacium LOI Amidst Consolidation

Executive Summary
  • Latest Development: On May 21, 2026, HPQ Silicon's partner Novacium SAS signed a non-binding Letter of Intent (LOI) with GH Technologies Co., Ltd. for the supply of GEN4 Li-Ion cells and batteries in Asia.
  • Scope: The agreement establishes a 36-month framework to evaluate supply and distribution across light electric mobility, embedded systems, and high-energy-density electronics.
  • Technical Specs: Novacium's GEN4 cells reported capacities exceeding 6,600 mAh and energy densities of 319.9 Wh/kg in this context.
  • HPQ Position: HPQ holds a 36.8% equity interest in Novacium SAS and maintains exclusive North American licensing rights for the ENDURA+ trademark.
  • Conditions: Finalization is subject to definitive purchase agreements, technical validation by GH Technologies' customers, and regulatory approvals.
Material Impact
  • Incremental Progression: The LOI represents a logical extension of previous commercial milestones (April drone orders in Europe) into the Asia-Pacific market but remains non-binding.
  • Revenue Recognition Risk: As an associate company investment (36.8% stake), HPQ does not consolidate Novacium's revenue; income is realized through royalties or dividends, which are not guaranteed by an LOI.
  • Market Expectations: The market has already priced in the technical validation from April 2026 (7,030 mAh cells); this news confirms commercial interest but does not introduce new technology capabilities.
  • Capital Implications: No immediate capital raise is announced alongside this LOI, suggesting the company is currently funding operations through previous placements ($3M in March 2026).
HPQ · Price
Company Overview
  • Core Business: HPQ Silicon focuses on two primary commercial platforms: silicon-based anode materials for lithium-ion batteries (via Novacium partnership) and plasma-based fumed silica production (HPQ Silica Polvere Inc.).
  • Flagship Project 1 (Batteries): The ENDURA+ battery platform utilizes GEN4 silicon anode technology. Recent milestones include IEC, UL, and UN certifications, enabling global shipping. Production capacity is subcontracted to Novacium's French facility with a target of 1.5 million cells per year.
  • Flagship Project 2 (Fumed Silica): The Fumed Silica Reactor (FSR) converts quartz directly to fumed silica using plasma technology, aiming for lower carbon emissions and costs compared to conventional methods. A joint venture with PyroGenesis is planned for a 1,000 tonne/year plant.
  • Development Stage: Transitioning from pilot validation to commercial scale-up; revenue generation is currently limited to early orders and testing phases.
Read the original news release →

More from HPQ Silicon Inc.